Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism EP300/CBP inhibitors(CREBBP/EP300 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H21FN4O4 |
InChIKeyBFOSEOLXWOXFQF-UHFFFAOYSA-N |
CAS Registry2450965-35-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Preclinical | CN | 16 May 2019 | |
Castration-Resistant Prostatic Cancer | Preclinical | CN | 16 May 2019 |